103 related articles for article (PubMed ID: 7911734)
21. Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.
Mian C; Pennelli G; Barollo S; Cavedon E; Nacamulli D; Vianello F; Negro I; Pozza G; Boschin IM; Pelizzo MR; Rugge M; Mantero F; Girelli ME; Opocher G
Eur J Endocrinol; 2011 Jun; 164(6):971-6. PubMed ID: 21422198
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of nuclear accumulation of c-myc and mdm2 proteins in synovial sarcoma of the extremities.
Shen J; Scotlandi K; Baldini N; Manara MC; Benini S; Cerisano V; Picci P; Serra M
Oncology; 2000 Apr; 58(3):253-60. PubMed ID: 10765129
[TBL] [Abstract][Full Text] [Related]
23. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.
Maio M; Coral S; Sigalotti L; Elisei R; Romei C; Rossi G; Cortini E; Colizzi F; Fenzi G; Altomonte M; Pinchera A; Vitale M
J Clin Endocrinol Metab; 2003 Feb; 88(2):748-54. PubMed ID: 12574209
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
Torresan F; Cavedon E; Mian C; Iacobone M
World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
[TBL] [Abstract][Full Text] [Related]
25. Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways.
Ameur N; Lacroix L; Roucan S; Roux V; Broutin S; Talbot M; Dupuy C; Caillou B; Schlumberger M; Bidart JM
Endocr Relat Cancer; 2009 Dec; 16(4):1261-72. PubMed ID: 19675075
[TBL] [Abstract][Full Text] [Related]
26. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
Yang Y
Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):304-6, 22. PubMed ID: 1667490
[TBL] [Abstract][Full Text] [Related]
27. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
[TBL] [Abstract][Full Text] [Related]
28. Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.
Ciampi R; Romei C; Pieruzzi L; Tacito A; Molinaro E; Agate L; Bottici V; Casella F; Ugolini C; Materazzi G; Basolo F; Elisei R
J Endocrinol Invest; 2017 Jan; 40(1):55-62. PubMed ID: 27535135
[TBL] [Abstract][Full Text] [Related]
29. c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.
La Rosa S; Bernasconi B; Vanoli A; Sciarra A; Notohara K; Albarello L; Casnedi S; Billo P; Zhang L; Tibiletti MG; Sessa F
Virchows Arch; 2018 Oct; 473(4):435-441. PubMed ID: 29721608
[TBL] [Abstract][Full Text] [Related]
30. An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for Cox-1 and Cox-2 enzymes.
Bell CD; Vidal S; Kovacs K; Horvath E; Rotondo F
Endocr Pathol; 2002; 13(4):331-40. PubMed ID: 12665651
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
32. Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma.
Gimm O; Dziema H; Brown J; Hoang-Vu C; Hinze R; Dralle H; Mulligan LM; Eng C
Oncogene; 2001 Apr; 20(17):2161-70. PubMed ID: 11360200
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
Frank-Raue K; Machens A; Leidig-Bruckner G; Rondot S; Haag C; Schulze E; Lorenz A; Kreissl MC; Dralle H; Raue F; Schmid KW
Thyroid; 2013 Mar; 23(3):294-300. PubMed ID: 22946486
[TBL] [Abstract][Full Text] [Related]
34. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
Xu YJ
Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
[TBL] [Abstract][Full Text] [Related]
35. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
36. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.
Zhang X; Xu Y; He C; Guo X; Zhang J; He C; Zhang L; Kong M; Chen B; Zhu C
J Surg Oncol; 2015 Jun; 111(7):834-9. PubMed ID: 25919911
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV
Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050
[TBL] [Abstract][Full Text] [Related]
38. Relationship of Amplification and Expression of the C-MYC Gene with Survival among Gastric Cancer Patients.
Khaleghian M; Shakoori A; Razavi AE; Azimi C
Asian Pac J Cancer Prev; 2015; 16(16):7061-9. PubMed ID: 26514491
[TBL] [Abstract][Full Text] [Related]
39. The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer.
Kebebew E; Treseler PA; Duh QY; Clark OH
Surgery; 2000 Dec; 128(6):952-7. PubMed ID: 11114629
[TBL] [Abstract][Full Text] [Related]
40. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
